Consistently, Bora was also an independent biomarker for adverse prognosis of OS (HR: 1.838, CI: 1.919 to 2.836, P = 0.006) and DFS (HR: 1.671, CI: 1.088 to 2.565, P = 0.019) in lung adenocarcinoma (Table 3). This evidence concerns the gene BORA and lung adenocarcinoma.